These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2745199)

  • 1. The risks of induced carcinogenesis after irradiation at small doses: the uncertainties which remain after the 1988 UNSCEAR report.
    Latarjet R; Tubiana M
    Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):237-40. PubMed ID: 2745199
    [No Abstract]   [Full Text] [Related]  

  • 2. [The levels of carcinogenic risk induced by low-dose irradiation. The uncertainties that remain after the publication of the 1988 UNSCEAR report].
    Latarjet R; Tubiana M
    Med Radiol (Mosk); 1990 Jul; 35(7):35-8. PubMed ID: 2374483
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary on UNSCEAR 2006 Report: Annex C--the new effects of radiation.
    Fairlie I
    Radiat Prot Dosimetry; 2010 Feb; 138(2):190-3. PubMed ID: 19942629
    [No Abstract]   [Full Text] [Related]  

  • 4. UNSCEAR 2000 published. United Nations Scientific Committee on the Effects of Atomic Radiation.
    Health Phys; 2001 Mar; 80(3):291. PubMed ID: 11219544
    [No Abstract]   [Full Text] [Related]  

  • 5. [Risk of postirradiation induction of cancer of the modern methods of radiotherapy (3D CRT and IMRT) head and neck cancer].
    Milecki P; Szyfter K; Skowronek J
    Otolaryngol Pol; 2004; 58(5):887-93. PubMed ID: 15732771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-induced second cancers: the impact of 3D-CRT and IMRT.
    Hall EJ; Wuu CS
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):83-8. PubMed ID: 12694826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatologic radiotherapy and thyroid cancer. Dose measurements and risk quantification.
    Goldschmidt H; Gorson RO; Lassen M
    Arch Dermatol; 1983 May; 119(5):383-90. PubMed ID: 6221697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [IMRT combined to IGRT: increase of the irradiated volume. Consequences?].
    Lisbona A; Averbeck D; Supiot S; Delpon G; Ali D; Vinas F; Diana C; Murariu C; Lagrange JL
    Cancer Radiother; 2010 Oct; 14(6-7):563-70. PubMed ID: 20729117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ-specific radiation-induced cancer risk estimates due to radiotherapy for benign pigmented villonodular synovitis.
    Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
    Phys Med Biol; 2016 Sep; 61(17):6400-12. PubMed ID: 27499236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiation-induced carcinogenesis following grid irradiation with a 27-year latency period].
    Wagner U; Morr H
    Med Klin (Munich); 1988 Mar; 83(6):228-30. PubMed ID: 2835641
    [No Abstract]   [Full Text] [Related]  

  • 11. Dosimetric risk estimates of radiation-induced malignancies after intensity modulated radiotherapy.
    Patil VM; Kapoor R; Chakraborty S; Ghoshal S; Oinam AS; Sharma SC
    J Cancer Res Ther; 2010; 6(4):442-7. PubMed ID: 21358077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Let's not relive the past: a review of cancer risk after diagnostic or therapeutic irradiation.
    Ron E
    Pediatr Radiol; 2002 Oct; 32(10):739-44; discussion 751-4. PubMed ID: 12244466
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiation dose and cancer risk to out-of-field and partially in-field organs from radiotherapy for symptomatic vertebral hemangiomas.
    Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
    Med Phys; 2016 Apr; 43(4):1841. PubMed ID: 27036581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation carcinogenesis in man: new primary neoplasms in fields of prior therapeutic radiation.
    Sadove AM; Block M; Rossof AH; Doolas A; Economou SG; Harris JE; Southwick HW; Hendrickson F; Wolter J
    Cancer; 1981 Sep; 48(5):1139-43. PubMed ID: 7272947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Out-of-field organ doses and associated radiogenic risks from para-aortic radiotherapy for testicular seminoma.
    Mazonakis M; Berris T; Varveris C; Lyraraki E; Damilakis J
    Med Phys; 2014 May; 41(5):051702. PubMed ID: 24784368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EVALUATION OF SECONDARY DOSE AND CANCER RISK FOR OUT-OF-FIELD ORGAN IN ESOPHAGEAL CANCER IMRT IN A CHINESE HOSPITAL USING ATOM PHANTOM MEASUREMENTS.
    Qi Y; He L; Wang Z; Liu Y; Liu H; Huo W; Xu XG; Chen Z
    Radiat Prot Dosimetry; 2017 Dec; 177(4):389-396. PubMed ID: 28472430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung carcinoma development after radiotherapy for breast carcinoma.
    Buchholz TA
    Cancer; 2003 Oct; 98(7):1331-3. PubMed ID: 14508817
    [No Abstract]   [Full Text] [Related]  

  • 18. Out-of-field doses from secondary radiation produced in proton therapy and the associated risk of radiation-induced cancer from a brain tumor treatment.
    Ardenfors O; Dasu A; Lillhök J; Persson L; Gudowska I
    Phys Med; 2018 Sep; 53():129-136. PubMed ID: 30241747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer after exposure to radiation in the course of treatment for benign and malignant disease.
    Little MP
    Lancet Oncol; 2001 Apr; 2(4):212-20. PubMed ID: 11905766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Exposure to ionizing radiation: radiobiological effects and pathogenesis. 1].
    Wambersie A; Smeesters P; Frühling J
    Rev Med Brux; 1996 Feb; 17(1):27-38. PubMed ID: 8720971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.